Corrigendum to 'Brief Report: Clinical Outcomes by Infusion Timing of Immune Checkpoint Inhibitors in Patients With Locally Advanced NSCLC' [JTO Clinical and Research Reports, Volume 5 Issue 4 (2024) 100659]

JTO Clin Res Rep. 2024 Nov 8;6(1):100761. doi: 10.1016/j.jtocrr.2024.100761. eCollection 2025 Jan.

Tsuyoshi Hirata¹, Yuji Uehara^{2

3}, Taiki Hakozaki¹, Takayuki Kobayashi¹, Yuto Terashima^{1

3}, Kageaki Watanabe¹, Makiko Yomota¹, Yukio Hosomi¹

¹ Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
² Department of Precision Cancer Medicine, Center for Innovative Cancer Treatment, Tokyo Medical and Dental University, Tokyo, Japan.
³ Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.

Abstract

[This corrects the article DOI: 10.1016/j.jtocrr.2024.100659.].